| RS1564509503 |
EHMT1
|
Health Risk |
Likely pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS1564515829 |
KAT6B
|
Health Risk |
Pathogenic |
— |
| RS1564516087 |
KAT6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Genitopatellar syndrome, Genitopatellar syndrome |
| RS1564516701 |
CUBN
|
Health Risk |
Pathogenic |
— |
| RS1564524282 |
TMC1
|
Health Risk |
Likely pathogenic |
— |
| RS1564526396 |
ODAD2
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 23, Primary ciliary dyskinesia 23 |
| RS1564532120 |
CHST3
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia with congenital joint dislocations, Spondyloepiphyseal dysplasia with congenital joint dislocations |
| RS1564532377 |
CHST3
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia with congenital joint dislocations, Spondyloepiphyseal dysplasia with congenital joint dislocations |
| RS1564537266 |
ASAH1
|
Health Risk |
Pathogenic |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS1564538809 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS1564540455 |
ASAH1
|
Health Risk |
Likely pathogenic |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS1564540693 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS1564544199 |
MYO3A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 30, Autosomal recessive nonsyndromic hearing loss 30 |
| RS1564544348 |
MYO3A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 30, Autosomal recessive nonsyndromic hearing loss 30 |
| RS1564545929 |
DOLK
|
Health Risk |
Pathogenic |
DK1-congenital disorder of glycosylation, DK1-congenital disorder of glycosylation |
| RS1564546510 |
DOLK
|
Health Risk |
Pathogenic |
DK1-congenital disorder of glycosylation, DK1-congenital disorder of glycosylation |
| RS1564554148 |
TMC1
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 7, Autosomal recessive nonsyndromic hearing loss 7 |
| RS1564554255 |
TMC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deafness, Hearing loss |
| RS1564555089 |
SYNE1
|
Health Risk |
Likely pathogenic |
— |
| RS1564555185 |
TMC1
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 7, Autosomal recessive nonsyndromic hearing loss 7 |
| RS1564555240 |
TMC1
|
Health Risk |
Pathogenic |
Deafness, Hearing loss |
| RS1564556995 |
TMC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 7, Hearing loss |
| RS1564557037 |
HK1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with visual defects and brain anomalies, Neurodevelopmental abnormality |
| RS1564564688 |
GSN
|
Health Risk |
Pathogenic |
Finnish type amyloidosis, Finnish type amyloidosis |
| RS1564566706 |
PTEN
|
Health Risk |
Pathogenic |
PTEN hamartoma tumor syndrome, Cowden syndrome 1 |
| RS1564566774 |
PTEN
|
Health Risk |
Pathogenic |
Thyroid cancer, nonmedullary |
| RS1564566801 |
PTEN
|
Health Risk |
Pathogenic |
PTEN hamartoma tumor syndrome, PTEN hamartoma tumor syndrome |
| RS1564566861 |
PTEN
|
Health Risk |
Pathogenic |
Ovarian neoplasm, Ovarian neoplasm |
| RS1564566998 |
PTEN
|
Health Risk |
Likely pathogenic |
PTEN-related disorder, Hereditary cancer-predisposing syndrome |
| RS1564568216 |
PTEN
|
Health Risk |
Pathogenic |
PTEN hamartoma tumor syndrome, PTEN hamartoma tumor syndrome |
| RS1564568265 |
PTEN
|
Health Risk |
Pathogenic |
PTEN hamartoma tumor syndrome, Cowden syndrome 1 |
| RS1564568303 |
PTEN
|
Health Risk |
Likely pathogenic |
Macrocephaly-autism syndrome, Macrocephaly-autism syndrome |
| RS1564568350 |
PTEN
|
Health Risk |
Pathogenic/Likely pathogenic |
Global developmental delay, Cowden syndrome 1 |
| RS1564568473 |
PTEN
|
Health Risk |
Pathogenic/Likely pathogenic |
PTEN hamartoma tumor syndrome, Hereditary cancer-predisposing syndrome |
| RS1564568546 |
SLC16A12
|
Health Risk |
Likely pathogenic |
— |
| RS1564568660 |
PTEN
|
Health Risk |
Pathogenic |
Endometrial carcinoma, Cowden syndrome 1 |
| RS1564568689 |
PTEN
|
Health Risk |
Likely pathogenic |
Cowden syndrome, Cowden syndrome |
| RS1564568719 |
PTEN
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, PTEN hamartoma tumor syndrome |
| RS1564568849 |
MYO3A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 30, Autosomal recessive nonsyndromic hearing loss 30 |
| RS1564570283 |
PTEN
|
Health Risk |
Pathogenic |
Ovarian neoplasm, Ovarian neoplasm |
| RS1564573788 |
MYO3A
|
Health Risk |
Pathogenic |
Nonsyndromic genetic hearing loss, nonsyndromic sensorineural hearing loss |
| RS1564574359 |
ACBD5
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, See cases |
| RS1564576117 |
LRMDA
|
Health Risk |
Pathogenic |
— |
| RS1564576546 |
COL27A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Steel syndrome, Steel syndrome |
| RS1564578862 |
COL27A1
|
Health Risk |
Pathogenic |
— |
| RS1564583413 |
TMC1
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 7, Autosomal recessive nonsyndromic hearing loss 7 |
| RS1564591135 |
ZMIZ1
|
Health Risk |
Likely pathogenic |
— |
| RS1564596167 |
KCNMA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy-paroxysmal dyskinesia syndrome, Generalized epilepsy-paroxysmal dyskinesia syndrome |
| RS1564602202 |
MYO3A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 30, Autosomal recessive nonsyndromic hearing loss 30 |
| RS1564606246 |
KAT6B
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS1564612961 |
POLR3A
|
Health Risk |
Likely pathogenic |
Neonatal pseudo-hydrocephalic progeroid syndrome, Neonatal pseudo-hydrocephalic progeroid syndrome |
| RS1564613755 |
POLR3A
|
Health Risk |
Pathogenic/Likely pathogenic |
Neonatal pseudo-hydrocephalic progeroid syndrome, Leukodystrophy |
| RS1564617848 |
POLR3A
|
Health Risk |
Pathogenic/Likely pathogenic |
Neonatal pseudo-hydrocephalic progeroid syndrome, Neonatal pseudo-hydrocephalic progeroid syndrome |
| RS1564617866 |
POLR3A
|
Health Risk |
Likely pathogenic |
Hypomyelinating leukodystrophy 4, Hypomyelinating leukodystrophy 4 |
| RS1564618717 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS1564620047 |
POLR3A
|
Health Risk |
Likely pathogenic |
Neonatal pseudo-hydrocephalic progeroid syndrome, Neonatal pseudo-hydrocephalic progeroid syndrome |
| RS1564622701 |
SGPL1
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome 14, Nephrotic syndrome 14 |
| RS1564623280 |
CDH23
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 12 |
| RS1564623882 |
POLR3A
|
Health Risk |
Pathogenic |
Neonatal pseudo-hydrocephalic progeroid syndrome, Neonatal pseudo-hydrocephalic progeroid syndrome |
| RS1564624254 |
POLR3A
|
Health Risk |
Likely pathogenic |
Leukodystrophy, hypomyelinating |
| RS1564625942 |
KAT6B
|
Health Risk |
Pathogenic |
— |
| RS1564626392 |
KAT6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, Intellectual disability |
| RS1564628151 |
PDZD7
|
Health Risk |
Pathogenic |
— |
| RS1564628365 |
KAT6B
|
Health Risk |
Pathogenic |
Genitopatellar syndrome, KAT6B-realted disoder |
| RS1564631871 |
DGAT1
|
Health Risk |
Pathogenic |
— |
| RS1564632292 |
KAT6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental disorder, KAT6B-related multiple congenital anomalies syndrome |
| RS1564632652 |
KAT6B
|
Health Risk |
Pathogenic |
Genitopatellar syndrome, Genitopatellar syndrome |
| RS1564634581 |
PDZD7
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS1564639645 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS1564641128 |
ACTA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Aortic aneurysm |
| RS1564641485 |
FANCC
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group C |
| RS1564645568 |
VPS13A
|
Health Risk |
Pathogenic/Likely pathogenic |
Chorea-acanthocytosis, Chorea-acanthocytosis |
| RS1564645686 |
MAT1A
|
Health Risk |
Pathogenic |
Hepatic methionine adenosyltransferase deficiency, Hepatic methionine adenosyltransferase deficiency |
| RS1564653469 |
LDB3
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 4, Myofibrillar myopathy 4 |
| RS1564653965 |
SLC52A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Brown-Vialetto-van Laere syndrome 2, Brown-Vialetto-van Laere syndrome 2 |
| RS1564654588 |
SUFU
|
Health Risk |
Pathogenic |
Gorlin syndrome, Medulloblastoma |
| RS1564657077 |
SUFU
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Gorlin syndrome |
| RS1564657463 |
SLC52A2
|
Health Risk |
Pathogenic |
Brown-Vialetto-van Laere syndrome 2, Brown-Vialetto-van Laere syndrome 2 |
| RS1564663863 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Dilated cardiomyopathy 1DD |
| RS1564663888 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Dilated cardiomyopathy 1DD |
| RS1564664312 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Dilated cardiomyopathy 1DD |
| RS1564666557 |
CDHR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Cone-rod dystrophy 15 |
| RS1564667078 |
NODAL
|
Health Risk |
Likely pathogenic |
Heterotaxy, visceral |
| RS1564667180 |
NODAL
|
Health Risk |
Likely pathogenic |
Heterotaxy, visceral |
| RS1564667617 |
NODAL
|
Health Risk |
Likely pathogenic |
Heterotaxy, visceral |
| RS1564667865 |
FANCC
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1564673127 |
COL17A1
|
Health Risk |
Pathogenic |
Epidermolysis bullosa, junctional 4 |
| RS1564673185 |
ABCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1564673999 |
BMPR1A
|
Health Risk |
Pathogenic |
Generalized juvenile polyposis/juvenile polyposis coli, Generalized juvenile polyposis/juvenile polyposis coli |
| RS1564674618 |
ABCC2
|
Health Risk |
Pathogenic |
— |
| RS1564676479 |
SUFU
|
Health Risk |
Pathogenic |
Medulloblastoma, Gorlin syndrome |
| RS1564677437 |
COL17A1
|
Health Risk |
Likely pathogenic |
Epidermolysis bullosa, junctional 4 |
| RS1564678441 |
FANCC
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group C, Fanconi anemia |
| RS1564678996 |
FANCC
|
Health Risk |
Likely pathogenic |
Ovarian cancer, Ovarian cancer |
| RS1564679226 |
COL17A1
|
Health Risk |
Likely pathogenic |
— |
| RS1564684815 |
COL17A1
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa, non-Herlitz type |
| RS1564685400 |
COL17A1
|
Health Risk |
Pathogenic |
Epithelial recurrent erosion dystrophy, Amelogenesis imperfecta type 1A |
| RS1564686301 |
FAS
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS1564687941 |
ABCC2
|
Health Risk |
Pathogenic |
ABCC2-related disorder, ABCC2-related disorder |
| RS1564688595 |
ABCC2
|
Health Risk |
Pathogenic |
— |